Smoking cessation reduces major cardiovascular events by almost half, study finds

According to research presented today at ESC Congress 2024, patients with stable coronary artery disease who quit smoking at any timepoint after their diagnosis reduced their risk of a major event by almost 50%.

Pharmalittle: We’re reading about Charles River monkey shipments, VC partners for Chinese companies, and more

Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping birds are enveloping the cozy

October 29, 2024

Low Relapse Rates With Twice-Yearly Schizophrenia Treatment

Every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) for schizophrenia was effective and safe up to 3 years, researchers reported during a poster

October 4, 2023

Catalent’s Indiana site closes out three Form 483s in past two years

One of Catalent’s three sites at the center of the Novo-Catalent deal has been hit by at least three form 483s in the past two

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.